Chief Financial Officer

EVP & Chief Operating Officer

Genmab Lymphoma Study Misses Key Target, Analyst Still Sees Upside

The week in pharma: action, reaction and insight – week to January 16, 2026

Genmab stock falls after Phase 3 epcoritamab trial misses key endpoint

AbbVie, Genmab’s Bispecific Misses Key Overall Survival Endpoint in Phase III Lymphoma Study

0.4285714328289032

Associate Director, US Market Insights Solid Tumor/Oncology

Genmab is an international biotechnology company dedicated to improving the lives of patients through innovative antibody therapeutics. The Associate Director, US Market Insights will lead market research initiatives and competitive intelligence to support the Head and Neck franchise, driving insights that inform commercial strategy and brand planning.

Executive Director and Chief Executive Officer

Group CFO and Executive Director

Unicorn Factory Lisboa – scaling to international horizons

AbelZeta Sells Remaining China Rights To GPC3 Armored CAR-T Program To AstraZeneca

GSK licenses Alteogen enzyme in bid to develop subQ Jemperli

Microfluidic Devices Market Size to Reach USD 17.09 Billion by 2033, Driven by Rapid Diagnostics and Lab-on-a-Chip Adoption – SNS Insider

0.5714285969734192

Associate Director – US Immuno-Oncology Marketing

AstraZeneca is dedicated to transforming the future of oncology and is seeking an Associate Director for their Immuno-Oncology Marketing team. This role involves developing and executing marketing strategies, leading cross-functional teams, and managing HCP campaigns to support the growth of AstraZeneca's IO portfolio.

SVP, Strategy and Business Development

Director, IRT and Technology Lead

Alexion Pharmaceuticals discloses C1S inhibitors

AstraZeneca Unit Gets Partial Win in Soliris Drug Monopoly Case

Complement C5 Inhibitors & C5 Receptor Antagonists Pipeline and Competitive Intelligence Report 2025 - ResearchAndMarkets.com

AstraZeneca Secures FDA Approval for Koselugo to Treat Adults with NF1 Plexiform Neurofibromas Following Positive Phase III KOMET Results

Alexion Pharmaceuticals, Inc. is dedicated to transforming the future of oncology by prioritizing patients and advancing science. The Associate Director, Immuno-Oncology will lead marketing strategies for the IO portfolio, manage cross-functional teams, and develop relationships with key stakeholders to promote AstraZeneca's oncology products.

Senior Vice President, Regeneron Pharmaceuticals, General Manager, Regeneron Genetics Center

Senior Vice President, Head Development Operations & Portfolio Management

Nation’s Top 40 High School Scientists to Compete for $1.8 Million in Awards at the Prestigious Regeneron Science Talent Search

JPM26: Regeneron will not overpay in M&A deals amid lead asset patent expiries

Genetic Therapy Aims To Bring Hearing To Those Born Deaf

STAT+: Regeneron’s chief scientist on Trump’s drug pricing policy, gene therapy, and the problem with AI

Senior Director, Oncology Marketing - US Lung Lead

Regeneron is a leading biotechnology company, and they are seeking a Senior Director for US Lung Marketing within their Oncology Business Unit. This role involves leading the marketing efforts for the NSCLC indication in the US, managing a team, and ensuring alignment with global strategies and performance objectives.

Senior Director, Oncology Marketing - US Skin Lead

Regeneron is a leading biotechnology company focused on developing innovative medicines for serious diseases. The Sr. Director, US Non-Melanoma Skin Cancer Skin Marketing will lead the marketing team responsible for the commercialization and performance of NMSC products in the US, collaborating with cross-functional teams and managing brand strategies.

VP, Head of Cell & Genetic Medicines Discovery

MeiraGTx Reports Second Quarter 2025 Financial and Operational Results

Interleukin-23 Inhibitors Market to Surge During the Forecast Period (2025-2034) Due to Demand for Targeted Autoimmune Therapies | DelveInsight

Urothelial Carcinoma Market Set to Expand During the Forecast Period (2025-2034) Amid Rising Incidence and Evolving Therapeutic Landscape | DelveInsight

Johnson & Johnson Innovative Medicine’s Tremfya Gains Momentum in Crohn’s Disease, Outpacing Eli Lilly’s Omvoh and Challenging AbbVie’s Skyrizi

0.8571428656578064

Director, Marketing Engagement & Education, US Oncology

Johnson & Johnson is a leader in healthcare innovation, committed to improving health outcomes. The Director of Marketing Engagement & Education for US Oncology will lead the Marketing Engagements & Education Team, focusing on strategy, operational excellence, and collaboration across various teams to enhance oncology marketing efforts.

Former Chairman and CEO, Johnson & Johnson

Chairman of the Board and Chief Executive Officer

Trump’s Drug Price Cuts: Boom or Bust for These 3 Pharma Giants

Johnson &amp; Johnson price target raised by $21 at Bernstein, here's why

Prostate Cancer Hormone Therapy Market to Reach US$ 79.89 Bn by 2032, Reports Persistence Market Research

Johnson & Johnson to Participate in the Guggenheim Securities 2nd Annual Healthcare Innovation Conference

Johnson & Johnson is a leader in healthcare innovation, dedicated to developing treatments and solutions for complex diseases. The Director of Marketing Engagement & Education for US Oncology will lead the Marketing Engagements & Education Team, focusing on strategy and operational excellence in speaker bureaus, sponsorships, and fee-for-service contracting to support oncology initiatives.